Wenkai Zhou

547 total citations
28 papers, 336 citations indexed

About

Wenkai Zhou is a scholar working on Molecular Biology, Ophthalmology and Oncology. According to data from OpenAlex, Wenkai Zhou has authored 28 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Ophthalmology and 7 papers in Oncology. Recurrent topics in Wenkai Zhou's work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (5 papers) and Retinal Diseases and Treatments (4 papers). Wenkai Zhou is often cited by papers focused on RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (5 papers) and Retinal Diseases and Treatments (4 papers). Wenkai Zhou collaborates with scholars based in China, United States and Thailand. Wenkai Zhou's co-authors include Dongquan Shi, Wei Cao, Zheqi Liu, Fangkun Zhao, Jun Xu, Chunxia Wang, Zhen‐Hu Ren, Chengzhong Lin, Wantao Chen and Ruixin Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Experimental Cell Research and Advanced Science.

In The Last Decade

Wenkai Zhou

26 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenkai Zhou China 10 195 139 44 31 31 28 336
Mustafa Kahraman Germany 12 259 1.3× 215 1.5× 31 0.7× 19 0.6× 21 0.7× 20 402
Enwu Xu China 9 246 1.3× 213 1.5× 33 0.8× 19 0.6× 62 2.0× 32 378
Cristine Dieter Brazil 9 116 0.6× 99 0.7× 23 0.5× 59 1.9× 54 1.7× 28 306
Anetta Sulewska Poland 12 210 1.1× 103 0.7× 36 0.8× 43 1.4× 49 1.6× 25 341
Anne Macgregor-Das United States 7 226 1.2× 166 1.2× 73 1.7× 39 1.3× 65 2.1× 7 346
Jinxiao Liang China 12 192 1.0× 83 0.6× 108 2.5× 63 2.0× 34 1.1× 24 366
Yiran Wang China 9 67 0.3× 39 0.3× 56 1.3× 38 1.2× 23 0.7× 40 250
Ting Xu China 10 99 0.5× 88 0.6× 103 2.3× 13 0.4× 34 1.1× 43 296
Angela C. Chen United States 10 90 0.5× 24 0.2× 49 1.1× 13 0.4× 28 0.9× 21 247

Countries citing papers authored by Wenkai Zhou

Since Specialization
Citations

This map shows the geographic impact of Wenkai Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenkai Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenkai Zhou more than expected).

Fields of papers citing papers by Wenkai Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenkai Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenkai Zhou. The network helps show where Wenkai Zhou may publish in the future.

Co-authorship network of co-authors of Wenkai Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Wenkai Zhou. A scholar is included among the top collaborators of Wenkai Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenkai Zhou. Wenkai Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yuying, Zhihao Wang, Tingcun Wei, et al.. (2025). Smurf2 Suppresses Proliferation and Cell Cycle of Triple‐Negative Breast Cancer Cells by Promoting the Polyubiquitination and Degradation of RPL35A. Journal of Cellular and Molecular Medicine. 29(2). e70394–e70394.
2.
Li, Mingyue, Tao Ye, Wenkai Zhou, et al.. (2024). LINC02454-CCT complex interaction is essential for telomerase activity and cell proliferation in head and neck squamous cell carcinoma. Cancer Letters. 588. 216734–216734. 2 indexed citations
4.
Wang, Xin, Yangyang Chai, Quan Yuan, et al.. (2024). NPM1 inhibits tumoral antigen presentation to promote immune evasion and tumor progression. Journal of Hematology & Oncology. 17(1). 97–97. 11 indexed citations
5.
Liu, Zheqi, Zhen Zhang, Yu Zhang, et al.. (2024). Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma. International Journal of Oral Science. 16(1). 9–9. 39 indexed citations
6.
Yang, Jie, Wenkai Zhou, Yang Wang, et al.. (2024). CAF‐secreted COL5A2 activates the PI3K/AKT pathway to mediate erlotinib resistance in head and neck squamous cell carcinoma. Oral Diseases. 31(2). 376–386. 3 indexed citations
7.
Zhou, Wenkai, et al.. (2023). Yin Yang 1‐Induced Long Noncoding RNA DUXAP9 Drives the Progression of Oral Squamous Cell Carcinoma by Blocking CDK1‐Mediated EZH2 Degradation. Advanced Science. 10(25). e2207549–e2207549. 21 indexed citations
8.
Zhou, Wenkai, et al.. (2023). The Heightened Importance of EZH2 in Cancer Immunotherapy. 0(0). 0–0. 2 indexed citations
9.
Zhou, Wenkai, Ting Zhao, Tianwei Qian, et al.. (2023). Efficacy and Safety of Implantable Collamer Lens V4c Implantation in 1,834 Myopic Eyes for 1 Year of Follow-up. Journal of Refractive Surgery. 39(10). 694–704. 5 indexed citations
10.
Xu, Weidong, et al.. (2023). Preoperative and postoperative complications as risk factors for delayed gastric emptying following pancreaticoduodenectomy: A single-center retrospective study. World Journal of Gastrointestinal Surgery. 15(9). 1941–1949. 2 indexed citations
11.
Qian, Tianwei, Yi Lu, Wenkai Zhou, et al.. (2023). SPARC-YAP/TAZ inhibition prevents the fibroblasts-myofibroblasts transformation. Experimental Cell Research. 429(1). 113649–113649. 9 indexed citations
12.
Zhou, Wenkai, et al.. (2022). Targeting cellular metabolism in head and neck cancer precision medicine era: A promising strategy to overcome therapy resistance. Oral Diseases. 29(8). 3101–3120. 10 indexed citations
13.
Zhang, Xu, Wenkai Zhou, Yu Zhang, & Zheqi Liu. (2022). CBX3 is a Prognostic Biomarker Correlated with ATR Activation and Immune Infiltration in Head and Neck Squamous Cell Carcinoma. SHILAP Revista de lepidopterología. 4 indexed citations
15.
Zhou, Wenkai, et al.. (2021). A novel clinical signature predicts the survival of elderly patients with oral squamous cell carcinoma. European Archives of Oto-Rhino-Laryngology. 279(1). 391–398. 5 indexed citations
16.
17.
Wu, Kun, Yingying Jiang, Wenkai Zhou, et al.. (2020). Long Noncoding RNA RC3H2 Facilitates Cell Proliferation and Invasion by Targeting MicroRNA-101-3p/EZH2 Axis in OSCC. Molecular Therapy — Nucleic Acids. 20. 97–110. 63 indexed citations
18.
Li, Ting, et al.. (2020). Let‐7c‐3p Regulates Autophagy under Oxidative Stress by Targeting ATG3 in Lens Epithelial Cells. BioMed Research International. 2020(1). 6069390–6069390. 18 indexed citations
19.
Zhao, Fangkun, Bei Shi, Ruixin Liu, et al.. (2018). Theme trends and knowledge structure on choroidal neovascularization: a quantitative and co-word analysis. BMC Ophthalmology. 18(1). 86–86. 37 indexed citations
20.
Zhao, Fangkun, et al.. (2017). Correlative factors’ analysis of postural-related ocular cyclotorsion with image-guided system. Japanese Journal of Ophthalmology. 62(2). 237–242. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026